Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-09-15FDA Approved: IRBESARTAN — Supplemental Application (Aurobindo Pharma Limited)
FDA approved the supplemental application for IRBESARTAN submitted by Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2014-09-15Clinical Trial Update: Action to Control Cardiovascular Risk in Diabetes (ACCORD) [Phase 3]
Phase 3 ACCORD trial evaluating strategies to reduce cardiovascular risk in people with diabetes; results were posted in 2014. The study inv…
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Veterans Service Organizations and My HealtheVet (MHV) [NA]
The VA-sponsored trial evaluating My HealtheVet in veterans with hypertension and hyperlipidemia has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Post-Marketing Surveillance Study of Micardis® Plus in Patients With Hypertension
This update reports the completion of a post-marketing surveillance study of Micardis Plus in patients with hypertension.
-
FDA approval · 2014-09-11FDA Approved: HYDRALAZINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves a supplemental application for Hydralazine hydrochloride (generic) from Teva Pharmaceuticals USA, Inc. Hydralazine is used to t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-09-11FDA Approved: HYDRALAZINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for hydralazine hydrochloride from Teva Pharmaceuticals USA, Inc., authorizing a change under an AND…
-
CLINICAL_TRIALS trial_result · 2014-09-11Clinical Trial Update: Can Group Visits Improve Outcomes of Veterans With Diabetes [Phase 3]
Phase 3 trial updating on group visits for veterans with diabetes and hypertension; results posted in 2014.
-
CLINICAL_TRIALS research · 2014-09-11Clinical Trial Update: Adherence and Intensification of Medications (AIM) Implementation Study [NA]
This AIM implementation study investigates adherence to and intensification of medications for diabetes mellitus and hypertension; results w…
-
FDA approval · 2014-09-11FDA Approved: HYDRALAZINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Hydralazine Hydrochloride (generic) from Teva Pharmaceuticals USA, Inc. under ANDA089097, confir…
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: A Randomised, Parallel-group, Double-blind, Double-dummy Study to Compare the Effects of Lacidipine Versus Bendrofluazide on Markers of Platelet Activation and Haemorheological Factors in Hypertensive Patients [Phase 4]
A Phase 4 randomized, double-blind trial comparing lacidipine and bendrofluazide in hypertensive patients to assess effects on platelet acti…
-
CLINICAL_TRIALS trial_result · 2014-09-08Clinical Trial Update: Comparison of Two Programs to Improve Blood Pressure Treatment Adherence [NA]
A completed Duke University trial comparing two programs designed to improve adherence to blood pressure treatment.
-
FDA approval · 2014-09-04FDA Approved: TRANDOLAPRIL — Supplemental Application (Epic Pharma, LLC)
FDA approved a supplemental application for Trandolapril tablets from Epic Pharma, LLC.
-
CLINICAL_TRIALS trial_result · 2014-09-03Clinical Trial Update: CKD-330 Drug-Drug Interaction Study (Candesartan) [Phase 1]
The study reports the completion of a phase 1 drug-drug interaction trial evaluating CKD-330 with candesartan in hypertension.
-
CLINICAL_TRIALS trial_result · 2014-09-03Clinical Trial Update: Sleep to Lower Elevated Blood Pressure [NA]
A completed clinical trial investigated whether sleep interventions can lower elevated blood pressure in individuals with hypertension and s…
-
CLINICAL_TRIALS trial_result · 2014-09-03Clinical Trial Update: Assistance Multidisciplinary in Hypertensive Patient: Randomized Clinical Trial [NA]
A randomized clinical trial evaluating multidisciplinary assistance for hypertensive patients has completed, sponsored by Instituto de Cardi…
-
CLINICAL_TRIALS research · 2014-08-29Clinical Trial Update: Treatment of Hypertension in Tibetan Adult Population [Phase 4]
This Phase 4 clinical trial update evaluates treatment of hypertension in Tibetan adults, sponsored by West China Hospital; the current stat…
-
CLINICAL_TRIALS trial_result · 2014-08-27Clinical Trial Update: Family-supported Smoking Cessation for Chronically Ill Veterans [NA]
This clinical trial update describes a family-supported smoking cessation program for chronically ill veterans. The study status is complete…
-
CLINICAL_TRIALS research · 2014-08-27Clinical Trial Update: Serum CTRP3 and RBP4 Levels in Obesity and Hypertension
A completed clinical trial investigating serum CTRP3 and RBP4 levels in obesity and hypertension, sponsored by Third Military Medical Univer…
-
FDA approval · 2014-08-27FDA Approved: METOPROLOL TARTRATE — Original Application (Almaject, Inc.)
FDA approved Almaject, Inc.'s metoprolol tartrate as an original Abbreviated New Drug Application (ANDA), establishing a generic version of …
-
FDA approval · 2014-08-26FDA Approved: TELMISARTAN AND AMLODIPINE — Original Application (Mylan Pharmaceuticals Inc.)
The FDA approved an Original Application for a fixed-dose combination tablet of telmisartan and amlodipine by Mylan Pharmaceuticals Inc. for…
-
CLINICAL_TRIALS trial_result · 2014-08-26Clinical Trial Update: Interactive Spaced Education to Optimize Hypertension Management [NA]
This clinical trial update reports results from an interactive spaced-education program designed to optimize hypertension management. The st…
-
FDA approval · 2014-08-26FDA Approved: TELMISARTAN — Original Application (Zydus Lifesciences Limited)
FDA approved the original ANDA for telmisartan from Zydus Lifesciences Limited, granting marketing authorization for a generic telmisartan p…
-
FDA approval · 2014-08-26FDA Approved: FUROSEMIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved Heritage Pharmaceuticals' generic furosemide (ANDA 203428) for edema-related indications and hypertension, enabling a generic v…
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: Study of Clevidipine Assessing Its Preoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-1) [Phase 3]
A Phase 3 trial evaluating clevidipine as a preoperative antihypertensive in cardiac surgery (ESCAPE-1) has completed. The study is sponsore…
-
CLINICAL_TRIALS trial_result · 2014-08-19Clinical Trial Update: Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure (PRONTO) [Phase 3]
Phase 3 trial PRONTO evaluated clevidipine for blood pressure control in patients with acute heart failure; results have been completed and …